Keywords
Lichen planus, oral
How to Cite
Abstract
Opiorphin is a pentapeptide, which could be isolated from human fluids and has a decreasing effect on pain. Aim: Since lichen planus is a chronic mucocutaneous disease, which causes pain or burning feeling in the oral mucosa, this study aimed to compare salivary opiorphin levels of oral lichen planus (OLP) patients with healthy subjects. Methods: This case-control study, was performed on 24 patients with OLP lesions and 21 healthy subjects. After collecting unstimulated saliva, opiorphin levels were compared between two groups through statistical analyses. Results: There was not any significant difference between OLP patients and healthy subjects according to salivary opiorphin concentration (p=0.378). Also, in the OLP group, opiorphin concentration was not significantly different between males and females (p=0.601). Analytical analysis could not show any remarkable difference between various severity of OLP lesions regarding to salivary opiorphin levels (p=0.653). Conclusion: In this study, salivary opiorphin levels was not significantly different between patients with OLP and healthy subjects; however, more studies are suggested for better assessment of salivary opiorphin levels in various types of OLP lesions and its correlation with pain severity.
References
Wisner A, Dufour E, Messaoudi M, Nejdi A, Marcel A, Ungeheuer MN, et al. Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways. Proc Natl Acad Sci U S A. 2006 Nov;103(47):17979-84. doi: 10.1073/pnas.0605865103.
Sujatha S, Priyadharshini R, Niloofar Khansari N, Yashoda Devi BK, Shwetha V, Pavan Kumar T, et al. An analgesic to bridge the gap between Narcotics and NSAIDs: opiorphin. Int J Basic Clin Pharmacol. 2018;7(7):1432-6. doi: 10.18203/2319-2003.ijbcp20182695.
Thongprasom K, Luangjarmekorn L, Sererat T, Taweesap W. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med. 1992 Nov;21(10):456-8. doi: 10.1111/j.1600-0714.1992.tb00974.x.
Shirzaiy M, Dalirsani Z. The effect of glycemic control on salivary lipid peroxidation in type II diabetic patients. Diabetes Metab Syndr. 2019 May-Jun;13(3):1991-4. doi: 10.1016/j.dsx.2019.04.004.
Javelot H, Messaoudi M, Garnier S, Rougeot C. Human opiorphin is a naturally occurring antidepressant acting selectively on enkephalin-dependent delta-opioid pathways. J Physiol Pharmacol. 2010 Jun;61(3):355-62.
Nejad NK, Ramakrishna P, Kar A, Sujatha S. Quantitative analysis and expression of salivary opiorphin in painful oral soft-tissue conditions: A descriptive study. J Global Oral Health. 2020;3(2):123-7. doi: 10.25259/JGOH_41_2020.
Sobocińska M, Salaga M, Fichna J, Kamysz E. Anti-inflammatory effect of homo- and heterodimers of natural enkephalinase inhibitors in experimental colitis in mice. Molecules. 2020 Dec;25(24):5820. doi: 10.3390/molecules25245820.
Kamysz E, Smolarczyk R, Cichoń T, Jarosz-Biej M, Sikorska E, Sobocińska M, et al. Antitumor activity of opiorphin, sialorphin and their conjugates with a peptide klaklakklaklak. J Pept Sci. 2016 Nov;22(11-12):723-30. doi: 10.1002/psc.2936.
Ozdogan MS, Gungormus M, Ince Yusufoglu S, Ertem SY, Sonmez C, Orhan M. Salivary opiorphin in dental pain: A potential biomarker for dental disease. Arch Oral Biol. 2019 Mar;99:15-21. doi: 10.1016/j.archoralbio.2018.12.006.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2022 Zohreh Dalirsani, Maryam Amirchaghmaghi, Ala Ghazi, Seyed Isaac Hashemy, Mahboobeh Taherizadeh
Downloads
